Optiver Holding’s Apogee Therapeutics APGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-242
Closed -$32.1K – 1824
2026
Q2
$32.1K Buy
242
+94
+64% +$8.47K ﹤0.01% 1321
2026
Q1
$12.5K Sell
148
-8
-5% -$581 ﹤0.01% 1180
2025
Q4
$11.8K Sell
156
-114
-42% -$7.18K ﹤0.01% 1112
2025
Q3
$10.7K Buy
+270
New +$10.3K ﹤0.01% 1255

Other funds holding APGE

Optiver Holding's APGE Position: Q3 2026 in Review

Optiver Holding sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 242 shares — an estimated $32.1K sold.

Optiver Holding first reported a position in APGE in Q3 2025 and held it in 4 quarters. The position peaked at $32.1K in Q2 2026. 2 funds tracked by Wall St. Rank hold APGE as of Q3 2026.

  • Optiver Holding reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Optiver Holding sold 242 Apogee Therapeutics shares in Q3 2026, an estimated $32.1K.
  • Optiver Holding first reported a position in Apogee Therapeutics in Q3 2025 and held it in 4 quarters.
  • Optiver Holding's Apogee Therapeutics position peaked at $32.1K in Q2 2026.
  • 2 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.

Based on Optiver Holding's 13F filing for Q3 2026, filed 16 Nov 2026.